Mater Private Network Treats World’s First Patient in Pioneering Cardiac Clinical Study

Mater Private Network is proud to announce a groundbreaking milestone in cardiac care, becoming the first institution globally to enrol a patient in the pioneering LUMINIZE clinical study. This first-in-human procedure, led by Professor Gábor Széplaki, Head of Cardiac Electrophysiology at Mater Private Network, was completed using the state-of-the-art VERAFEYE™ Navigation and Visualisation Platform from LUMA Vision Ltd.  The VERAFEYE™ system revolutionises intracardiac imaging by combining advanced manoeuvrability with cutting-edge imaging technology to deliver real-time, four-dimensional, CT-quality anatomical reconstructions in under 60 seconds.

With plans to enrol patients with complex heart conditions such as atrial fibrillation (A Fib) and structural heart disease over the coming months, Mater Private Network is leading the charge for advanced cardiac care in Ireland. 

Speaking about his role in the trial, Professor Széplaki, Head of Cardiac Electrophysiology at the Mater Private Network, remarked: "At Mater Private Network, we are always striving to be at the forefront of medical innovation and our participation in this trial is a great example of how our cardiology centre, in collaboration with the researchers at the Cardiovascular Research Institute (CVRI) Dublin and RCSI University of Medicine and Health Sciences, has become a centre of excellence for research and clinical care here in Ireland.”

The inclusion of Mater Private Network patients in this trial highlights the hospital’s subspecialty expertise in this field, employing the most AFib specialist cardiologists and treating the highest volume of AFib patients in Ireland. This trial, driven by Mater Private Network’s continued collaboration with the CVRI Dublin and RCSI, provides unparalleled access to innovative treatments previously inaccessible to Irish patients. 

The VERAFEYE™ system offers 360-degree visualisation with enhanced depth and clarity, overcoming the limitations of traditional two-dimensional imaging, and enabling clinicians to navigate and visualise cardiac anatomy dynamically from all angles. Ultimately this technology provides crucial support for complex cardiac interventions enhancing accuracy, efficiency, and safety in advanced electrophysiology procedures.

Mater Private Network, as a leader in cardiac care here in Ireland, is proud to continue to support and engage with innovative advances in cardiac medicine, to improve patient outcomes both in Ireland and beyond.